Purchase Order 36C26123P0590

Award Date 1/26/23
Potential Completion Date 1/30/23
Potential Value $85K
Ultimate Awardee
CVS Health Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the procurement of four pharmacy orders by the Veterans Affairs (VA) Integrated Service Network 19 (VISN 19). The award was made to Caremark RX, L.L.C., a for-profit limited liability company that provides pharmaceuticals and related services. The contract is a firm fixed-price purchase order with a ceiling value of $78,476.16 and a completion date of September 30, 2016. Caremark has provided specialty medications, including treprostinil-based drugs for...
This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
This is a $81,632.25 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit subsidiary of Express Scripts that specializes in providing specialty pharmaceutical services. The contract is for the delivery of the medication Tyvaso, which is used to treat pulmonary arterial hypertension. The contract has no set-aside designation and was awarded on April 6, 2021, with a completion date of September 30, 2021....
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Caremark, L.L.C., a for-profit limited liability company, for the provision of Remodulin medication. The contract has a potential value of $131,419.80 and a completion date of September 30, 2020. The medication is to be delivered to the VA's Veterans Integrated Service Network 23 in Redlands, CA. The contract was not set aside. Caremark, L.L.C. has previously been...
This firm fixed price BPA call order was awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $101,422.89 order procured Tyvaso inhalation solution and starter/refill kits, as well as other pulmonary arterial hypertension and cancer treatments, to support VA distribution of these specialty medications to veterans nationwide. The order was placed against United Therapeutics'...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $31,085.18, is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract is a delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for...
<p>This is a firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency of the U.S. federal government, to Procare Pharmacy Direct, L.L.C. (doing business as CVS Caremark). The contract, with a ceiling value of $19,887.06, is for the delivery of medication. The contract has a period of performance ending on February 7, 2025, and was awarded on January 29, 2025. There is no set-aside designation mentioned for this contract.</p>
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $32,063.20, is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract was awarded under United Therapeutics' Federal Supply Schedule (FSS) contract for...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,557 purchase order to Accredo Health Group, Inc. to deliver TYVASO in Palo Alto, California from January 18, 2023 through April 18, 2023. As a prime contractor supporting VA's Veterans Integrated Service Network 21, Accredo Health Group will provide the pulmonary arterial hypertension medication on a firm fixed price basis. No subcontractors or set aside designations were indicated. This purchase order was issued...
This is a firm fixed price delivery order for $85,327.92 awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for Tyvaso, a pulmonary arterial hypertension medication, and is being made against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics has received over 50...

This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Caremark RX, L.L.C., a subsidiary of CVS Health Corporation, for the emergency delivery of Tyvaso, a medication used to treat pulmonary arterial hypertension. The contract has a ceiling value of $85,327.92 and an ultimate completion date of January 30, 2023. The award does not contain a set-aside designation. Caremark RX has a history of providing specialty pharmaceuticals, including Tyvaso and other pulmonary hypertension medications, directly to VA medical facilities through similar short-term purchase orders. This contract supports the VA's mission to provide comprehensive healthcare services to eligible veterans.

Generated 4/1/25, 4:51 PM